-+ 0.00%
-+ 0.00%
-+ 0.00%

Finnair (HLSE:FIA1S) Stock Price Sours Despite Firm Q3 Earnings

Simply Wall St·10/28/2026 01:24:56
Listen to the news

Finnair Oyj just posted its Q3 2026 scorecard and the headline is simple: profit is holding up while the share price mood stays sour. The stock closed at €4.17 on 27 October, capping a 7‑day slide of about 3.6% and a 3‑month drop of roughly 12.5%.

Inside the release, comparable operating profit of €84m and revenue of €973.4m tell a calmer story than the chart. The market is trading the fear that good news will not last, and the numbers point to investors reassessing sentiment more than fundamentals today.

Like the resilience in Finnair Oyj’s profit line but uneasy about a share price that keeps drifting lower? Compare this setup with our 195 high quality undervalued stocks to see how other companies with solid business metrics are being priced by the market.

Q3 2026 Earnings Summary

  • Revenue (Q3 2026 vs. Q3 2025): €973.4 million vs. €834.9 million (up 14.2%)
  • Net Income (Excl. Extra Items, Q3 2026 vs. Q3 2025): €59.1 million vs. €30.5 million (up 93.8%)
  • Basic EPS (Q3 2026 vs. Q3 2025): €0.29 per share vs. €0.15 per share (up 93.3%)
  • Available Seat Kilometers (ASK, Q3 2026 vs. Q3 2025): 10,411 million vs. 10,474 million (slightly lower capacity)

Prefer clean visuals instead of scrolling through dense earnings tables and raw figures for Finnair Oyj? See the airline's full financial picture with an at-a-glance view of profitability trends in the company report for Finnair Oyj.

HLSE:FIA1S Trailing 12-Month Revenue & Expenses Breakdown as at Oct 2026
HLSE:FIA1S Trailing 12-Month Revenue & Expenses Breakdown as at Oct 2026

Evaluating Finnair’s Growth Ambition Against Q3 Reality

The bullish view hinges on Finnair turning fleet growth and hub strength into steady, profitable expansion rather than chasing volume for its own sake.

"Planned fleet expansion with secondhand Airbus A320 aircraft, new Embraer E2 orders and one additional A350 supports the communicated 4% annual growth ambition. This can increase available capacity and help scale revenue while spreading fixed costs to support net margins."

Q3 results support that ambition being on track. Revenue rose 14.2% while capacity, measured in Available Seat Kilometers, was slightly lower year on year. That points to pricing and mix doing the heavy lifting, not just extra seats, which is aligned with a margin focused growth plan.

Not everyone reads the same price the same way. → See the lower figure this Narrative lands on, and how it gets there.

Finnair Bear Case: Fuel And Capacity Fears On Trial

The darker take on Finnair argues that fuel and fleet bets could swamp today’s profitability.

"The long sector lengths caused by closed Russian airspace mean fuel remains a structurally large cost item. As existing fuel hedges roll off at declining hedge ratios, any sustained fuel price pressure could materially squeeze CASK, EBIT margin and cash flow."

Q3 results show this risk starting to bite at the edges. Management called out higher effective jet fuel costs and fresh EU ETS and SAF charges adding roughly €10m per quarter. Fuel hedging for 2027 sits at only 34%, so the protection visible in 2026 cash flow is not yet locked for later years.

Hunt For Quiet Mispricings

Finnair Oyj illustrates how profit resilience and share price caution can coexist for a long time. The real opportunity is finding stocks that could be undervalued before the market corrects them.

  • Company 1 - 37% below our estimate - builds commercial aircraft as a long term industrial project born from national champions. The real opportunity is finding stocks that could be undervalued before the market corrects them.
  • Company 2 - 19% below our estimate - sells software defined routers and subscriptions that orchestrate wired, wireless and satellite links in one place. The real opportunity is finding stocks that could be undervalued before the market corrects them.
  • Company 3 - 20% below our estimate - supplies complex generic and over the counter medicines as funded programs increase demand for lower cost treatments. The real opportunity is finding stocks that could be undervalued before the market corrects them.

That is three of the list. See all 195 potentially undervalued companies →